| Literature DB >> 35530369 |
Shahzaib Ahmad1, Fatima Yasin1, Manas Pustake2, Hadin Darain Khan3, Inês F Silva Correia4.
Abstract
Entities:
Year: 2022 PMID: 35530369 PMCID: PMC9060710 DOI: 10.1016/j.amsu.2022.103670
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Comparison of COVID-19 and dengue fever [[2], [3], [4], [5], [6], [7]].
| COVID-19 | Dengue Fever | |
|---|---|---|
| Clinical Features | Primarily cough and shortness of breath | Nausea, vomiting, rash, aches and pains (eye pain, typically behind the eyes, muscle, joint or bone pain) |
| Diagnosis | RT-PCR | NAAT and Serology |
| Prognosis | Variable | Poor |
| Risk Groups and Risk Factors | Close contact with infected person/Immunosuppression | Age >6 years, hepatomegaly, abdomen pain and oliguria were the most common risk factors associated with shock in children with Dengue fever |
| Treatment | Symptomatic (other drugs are under trial) | Under Trial |
| Vaccination | Undertrial (WHO has approved several for emergency use) | Under development |